About Us

Archives






Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of Directors

Posted: July 5, 2021 at 1:51 am


IRVINE, Calif., July 02, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (ALS), today announced the appointment of Jan Hillson, M.D., to the company’s Board of Directors. Dr. Hillson currently serves as Senior Vice President of Clinical Development at Alpine Immune Sciences, a clinical stage biopharmaceutical company dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to treat cancer and autoimmune and inflammatory diseases.

See the original post here:
Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of Directors

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.